droxidopa has been researched along with isoproterenol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lyman, CP; O'Brien, RC | 1 |
| Feigenbaum, JJ; Fishman, RH; Klawans, HL; Yanai, J | 1 |
| Amabeoku, GJ; Syce, JA | 1 |
| Bartlett, P; Fernandes, K; Hein, L; Jha, S; Jhaveri, D; Ladiwala, U; Marathe, SV; Muthig, V; Rommelfanger, K; Vadodaria, KC; Vaidya, VA; Weinshenker, D; Yanpallewar, SU | 1 |
4 other study(ies) available for droxidopa and isoproterenol
| Article | Year |
|---|---|
A pharmacological study of hibernation in rodents.
Topics: Adrenalectomy; Amphetamine; Animals; Bromocriptine; Cricetinae; Droxidopa; Epinephrine; Hibernation; Isoproterenol; Levodopa; Mesocricetus; Norepinephrine; Phenylephrine; Sciuridae | 1988 |
The relative importance of dopamine and norepinephrine in mediating locomotor activity.
Topics: Adrenergic Antagonists; Amphetamines; Animals; Apomorphine; Biomechanical Phenomena; Brain Chemistry; Catecholamines; Clonidine; Corpus Striatum; Dopamine; Droxidopa; Isoproterenol; Levodopa; Limbic System; Locomotion; Neural Pathways; Neurotransmitter Agents; Norepinephrine; Nucleus Accumbens; Propranolol; Receptors, Dopamine; Reserpine; Serotonin; Serotonin Antagonists; Substantia Nigra; Tetrahydronaphthalenes | 1983 |
Propranolol-induced seizures in mice: the role of noradrenaline.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Disulfiram; Droxidopa; Drug Synergism; Female; Imipramine; Isoproterenol; Male; Mice; Norepinephrine; Pargyline; Propranolol; Reserpine; Seizures | 1997 |
Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Antiparkinson Agents; Ascorbic Acid; Behavior, Animal; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cells, Cultured; Dopamine beta-Hydroxylase; Doublecortin Domain Proteins; Droxidopa; Drug Administration Schedule; Drug Interactions; Embryo, Mammalian; Female; Gene Expression Regulation, Developmental; Hippocampus; Imipramine; In Vitro Techniques; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microtubule-Associated Proteins; Nerve Tissue Proteins; Neurogenesis; Neuropeptides; Phenylephrine; Pregnancy; Prenatal Exposure Delayed Effects; Proliferating Cell Nuclear Antigen; Rats; Rats, Wistar; Reaction Time; Receptors, Adrenergic, alpha-2; Stem Cells; Yohimbine | 2010 |